INS and type 2 diabetes mellitus: Another significant study in this field, the First Basal Insulin Evaluation (FINE) Asia study, was a multinational, prospective, observational approach to assess BI’s efficacy in patients with uncontrolled type 2 diabetes (HbA1c ≥8%) [22].